40

years breakthroughs stories

40 years of extraordinary connections

A 40 year journey shaping extraordinary links between elite life science talent and pioneering medical organisations. Showcasing the revolutionary impact that results from connecting innovative leaders and celebrating the incredible people behind the growth and advancement of the life science and healthcare sectors around the world.

1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1982
1993
1994
1995
1996
1997
1988
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2019
2021
First Genetically Engineered...

First Genetically Engineered...

First office opens in St Albans

Theory of Multiple Intelligences...

Theory of Multiple Intelligences...

Steve draws on his network

DNA fingerprint uncovered...

DNA fingerprint uncovered..

RSA Consulting Limited is formed

Human TP53 gene was cloned...

Human TP53 gene was cloned...

RSA ‘trusted advisor’ concept

Eli Lilly for mental healthcare...
Merck’s statin medication...

Merck’s statin medication...

First Locum (interim) placed

 

Patricia Bath patents Probe...

Patricia Bath patents Probe...

RSA Quality system implemented

Cambridge Antibody Technology...
Human Genome Project
First takotsubo cardiomyopathy...
The Wellcome Trust...
Huntington's Disease gene...
First Alzheimer's disease gene...
National Institutes of Health...

National Institutes of Health...

Nick joins as a Researcher

Cloning of Dolly the sheep...

Cloning of Dolly the sheep...

Global reach of clients grows

KLOTHO aging gene discovered...

KLOTHO aging gene discovered...

RSA extends and grows UK office

DuPont gets FDA Clearance...
GW pharma starts first clinical...
Human genome mapped...

Human genome mapped...

Nick becomes Managing Director

First Gene-Targetted Drug...

First Gene-Targetted Drug...

RSA appoints first NEDs

Synthetic Viruses and Biological...

Synthetic Viruses and Biological...

RSA Interims is launched

FDA approves Palivizumab...

FDA approves Palivizumab...

Frankfurt office opens

John Van Tam - Public Health...

John Van Tam - Public Health...

Faculty of Pharmaceutical Medicine

Chris Whitty appointed to...
FDA Approval Cancer Vaccine...

FDA Approval Cancer Vaccine...

RSA celebrates 25 years

Stem cells from mature skin cells...

Stem cells from mature skin cells...

Switzerland office opens

Two women share Nobel Prize...

Two women share Nobel Prize...

Times International Track 100

HIV prophylaxis...

HIV prophylaxis...

Best UK Interim Recruiter Award

Cell replication and ageing...

Cell replication and ageing...

RSA celebrates 30 years

Discovery of CRISPR Genome...
Understanding human microbiome...
Robotic limbs controlled by brain...
Discovery of Teixobactin...
MiNA Therapeutics kicks off...
CAR -T Therapy for Cancer...
Single cell tracking techniques...
Changing the course of disease...
COVID-19 Testing Programme...

COVID-19 Testing Programme...

RSA rebrand & website launch

Covid-19 Vaccine development...

Covid-19 Vaccine development...

RSA celebrates 40 years

Adam Aspinall

Senior Director, Access & Product Management, Medicines for Malaria Venture | Honorary Fellow, Durham University Business School | Chair, Fight the Fakes Alliance

Adrian Cottrell

CIO at The Institute of Cancer Research in London

William Burns

Company Director at Shire, Mesoblast, Vestergaard, Molecular Partners, Wellcome Trust; Institute of Cancer Research London

Bruno Febra

Head of Commercial and Business Development Generics EU/ROW | Management team at Alter Pharma Group

Dr. Carsten von Blohn

BPL Bioproduct Laboratory GmbH Interim General Manager, PlanB GmbH Founder and General Manager, Speaker of Expert Group Healthcare in DDIM and Member Management Board of Healthcare Shapers

Christian Joergensen

International CEO, Chairman and Non-Exec Board Member

Dr. Colton Wong

Senior Director at Wuxi AppTec China.

David Arias Gayo

General Manager Mibe Pharma Spain and Allergopharma Spain

Dr. Dieter Braun

Head Specialty Brands and Hospital Business at Accord Healthcare

Elmar Schnee

Chairman and Board Member

Dr. Fabio Magrini

Principal Medical Director USMA Neuroscience at Genentech.

Dr. Francois Martelet

NED Novigenix SA, CEO Osamia Pharmaceutical AB

Gareth Waldron

Director, Development Non-Clinical Safety at Sosei Heptares

Dr Huw Jones

Chief Executive Officer at Evgen Pharma PLC.

Dr. Glen Clack

Chief Medical Officer at Evgen Pharma PLC.

Graham Price

Head Translational Medicine, UCB New Medicines at UCB

Dr. Heather Preston

Managing Partner at Pivotal BioVentures

Giacomo Mordenti

Head of Biostatistics & Data Management Europe at Daiichi Sankyo Europe GmbH.

Ian Crosbie

Chief Executive Officer at Sequana Medical NV

James Culley

Director at JRC Consultancy

John Overington

CIO, Medicines Discovery Catapult

Jordi Clarimon

Biofluid Lead Specialist. Translational Biomarkers and Imaging Group. Experimental Medicine Department at Lundbeck A/S

Nick Page

COO at Oxford BioMedica

Nigel Brooksby

Chairman and Non-Executive Director at Neurocentrx Pharma Limited

Professor Peter Simpson

CSO at Medicines Discovery Catapult.

Pierre van Weperen

CEO at Grow Pharma, Managing Director at Grow Group UK and Chair of the Board at Dutch National MS Society

Samantha Nickerson

Country Lead UK and Ireland at Camurus

Sebastian Hallworth

Head of ADMET Services at Concept Life Sciences

Simon Collis

Director, Global Commercial and Business Development at Britannia Pharmaceuticals Ltd

Tim Watts

CEO at Shield Therapeutics

Yann Guivarch

Health financing project manager, Institut National du Cancer, Secretary General, CARPEM, and Finance and Administration Manager, Clinical Research at The Georges Pompidou European Hospital.

Ahmed Al-Derzi

CEO and Board Member at Consilient Health

Amir Inamdar

Chief Medical Officer at Cybin

Dr Angelico Carta

MD and Co-Founder of Worldwide Clinical Trials

Dr Christoffer Jensen

Head of Neurology, Medical Strategy and Communication at Lundbeck

David Impey

Partner at Saiga Life Sciences Capital

Giuseppe Mazza, PhD

Co-Founder and CEO at Engitix

Graham Mullis

Group CEO at Novacyt

Holger Montag

Country Head at Micro Labs

Dr Ian Hudson

OBE, Senior Advisor for Integrated Development at The Bill and Melinda Gates Foundation

Dr Segundo Mariz

Scientific Administrator at EMA

Simon Higginbotham

Chief Marketing Officer at Parexel

Steve Bates

CEO at BioIndustry Association

Stuart Paynter

Chief Financial Officer at Oxford Biomedica